The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections
Open accessAbstract
Despite significant research efforts aimed at understanding the neurobiological underpinnings of psychiatric disorders, the diagnosis and the evaluation of treatment of these disorders are still based solely on relatively subjective assessment of symptoms. Therefore, biological markers which could improve the current classification of psychiatry disorders, and in perspective stratify patients on a biological basis into more homogeneous clinically distinct subgroups, are highly needed. In order to identify novel candidate biological markers for major depression and schizophrenia, we have applied a focused proteomic approach using plasma samples from a large case-control collection. Patients were diagnosed according to DSM criteria using structured interviews and a number of additional clinical variables and demographic information were assessed. Plasma samples from 245 depressed patients, 229 schizophrenic patients and 254 controls were submitted to multi analyte profiling allowing the evaluation of up to 79 proteins, including a series of cytokines, chemokines and neurotrophins previously suggested to be involved in the pathophysiology of depression and schizophrenia. Univariate data analysis showed more significant p-values than would be expected by chance and highlighted several proteins belonging to pathways or mechanisms previously suspected to be involved in the pathophysiology of major depression or schizophrenia, such as insulin and MMP-9 for depression, and BDNF, EGF and a number of chemokines for schizophrenia. Multivariate analysis was carried out to improve the differentiation of cases from controls and identify the most informative panel of markers. The results illustrate the potential of plasma biomarker profiling for psychiatric disorders, when conducted in large collections. The study highlighted a set of analytes as candidate biomarker signatures for depression and schizophrenia, warranting further investigation in independent collections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
An introduction to ROC analysis
Fawcett, T. (2006) · Pattern Recognition Letters · doi:10.1016/j.patrec.2005.10.010 · Cited by 21,879
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 1×
“Multi-analyte and array profiling techniques enable the simultaneous detection of hundreds of proteins with high sensitivity and accuracy and can be successfully applied to identify biomarkers (or clusters of biomarkers) that correlate with disease [7].”
BackgroundCytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Wittchen, H.-U., Lachner, G., Wunderlich, U., & Pfister, H. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050095 · Cited by 668
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622 · cited 1×
“Increased circulating levels of IL-6 and TNF-a were described in a consistent susceptible population of patients suffering from Major Depressive Disorders during the symptomatic episode [31–35] and correlation Figure 5.”
BackgroundCytokine Dysregulation, Inflammation and Well-Being
Elenkov, I. J., Iezzoni, D. G., Daly, A., Harris, A. G., & Chrousos, G. P. (2005) · Neuroimmunomodulation · doi:10.1159/000087104 · Cited by 502
Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory
Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R. M., Silva, A. J., Kaczmarek, L., & Huntley, G. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4359-05.2006 · Cited by 499
Cytokines as mediators of depression: what can we learn from animal studies?
Dunn, A. J., Swiergiel, A. H., & Beaurepaire, R. D. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.023 · Cited by 459
A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia
Need, A. C., Ge, D., Weale, M. E., Maia, J., Feng, S., Heinzen, E. L., Shianna, K. V., Yoon, W., Kasperavičiūtė, D., Gennarelli, M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000373 · Cited by 447
Self-citationTuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets
Ethell, I. M., & Ethell, D. W. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21273 · Cited by 378 · cited 2×
“MMPs have many other properties, including the ability to modulate cytokines and growth factors (such as TNF-alpha and BDNF among others) by processing their proforms into active forms [22].”
BackgroundAlesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1667 · Cited by 372
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341 · cited 3×
“For depression, the most robust laboratory finding is probably the HPA dysfunction of depressed patients during acute phase, which has led to the development of neuroendocrine challenge tests as putative biomarkers with potential application in clinical context [3].”
BackgroundMethodSelf-citationThe Comorbidity of Diabetes Mellitus and Depression
Katon, W. J. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.008 · Cited by 307
Mikova, O., Yakimova, R., Bosmans, E., Kenis, G., & Maes, M. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00081-5 · Cited by 305
A detailed examination of cytokine abnormalities in Major Depressive Disorder
Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286
Chowdhury, F., Williams, A., & Johnson, P. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.10.002 · Cited by 284
Muglia, P., Tozzi, F., Galwey, N. W., Francks, C., Upmanyu, R., Kong, X. Q., Antoniades, A., Domenici, E., Perry, J., Rothen, S., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.131 · Cited by 265
Self-citationOkamura, F., Tashiro, A., Utumi, A., Imai, T., Suchi, T., Tamura, D., Sato, Y., Suzuki, S., & Hongo, M. (2000) · Metabolism · doi:10.1053/meta.2000.9515 · Cited by 241
Depression: An Important Comorbidity With Metabolic Syndrome in a General Population
Dunbar, J. A., Reddy, P., Davis-Lameloise, N., Philpot, B., Laatikainen, T., Kilkkinen, A., Bunker, S. J., Best, J. D., Vartiainen, E., Kai Lo, S., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0175 · Cited by 241
Hestad, K. A., Tønseth, S., Støen, C. D., Ueland, T., & Aukrust, P. (2003) · The Journal of ECT · doi:10.1097/00124509-200312000-00002 · Cited by 235 · cited 1×
“Increased circulating levels of IL-6 and TNF-a were described in a consistent susceptible population of patients suffering from Major Depressive Disorders during the symptomatic episode [31–35] and correlation Figure 5.”
BackgroundInsulin resistance after oral glucose tolerance testing in patients with major depression
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.3.325 · Cited by 203
Bozdagi, O., Nagy, V., Kwei, K. T., & Huntley, G. W. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00202.2007 · Cited by 182
Depression, comorbidities and the TNF-α system
Himmerich, H., Fulda, S., Linseisen, J., Seiler, H., Wolfram, G., Himmerich, S., Gedrich, K., Kloiber, S., Lucae, S., Ising, M., et al. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.03.013 · Cited by 181
Self-citationGama, C. S., Andreazza, A. C., Kunz, M., Berk, M., Belmonte-de-Abreu, P. S., & Kapczinski, F. P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.001 · Cited by 172
TIMP-1 Abolishes MMP-9-Dependent Long-lasting Long-term Potentiation in the Prefrontal Cortex
Okulski, P., Jay, T. M., Jaworski, J., Duniec, K., Dzwonek, J., Konopacki, F. A., Wilczynski, G. M., Sánchez‐Capelo, A., Mallet, J. J., & Kaczmarek, L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.012 · Cited by 163
Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics
GRILLO, R., OTTONI, G., LEKE, R., SOUZA, D., PORTELA, L., & LARA, D. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.005 · Cited by 159
Factor structure and external validity of the PANSS revisited
van den Oord, E. J. C. G., Rujescu, D., Robles, J. R., Giegling, I., Birrell, C. E., Bukszár, J., Murrelle, L., Möller, H., Middleton, L. T., & Muglia, P. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.09.002 · Cited by 154
Self-citationFutamura, T., Toyooka, K., Iritani, S., Niizato, K., Nakamura, R., Tsuchiya, K., Someya, T., Kakita, A., Takahashi, H., & Nawa, H. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001081 · Cited by 146
Shimizu, E., Hashimoto, K., Watanabe, H., Komatsu, N., Okamura, N., Koike, K., 篠田, 直., Nakazato, M., Kumakiri, C., Okada, S.-I., et al. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.004 · Cited by 146
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 143
Ikeda, Y., Yahata, N., Ito, I., Nagano, M., Toyota, T., Yoshikawa, T., Okubo, Y., & Suzuki, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.017 · Cited by 143
Major depression and impaired glucose tolerance
Weber, B., Schweiger, U., Deuschle, M., & Heuser, I. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-7742 · Cited by 116
Krishhan, V. V., Khan, I. H., & Luciw, P. A. (2009) · Critical Reviews in Biotechnology · doi:10.1080/07388550802688847 · Cited by 114
Kubera, M., Kenis, G., Bosmans, E., Zieba, A., Dudek, D., Nowak, G., & Maes, M. H. J. (2000) · PubMed · Cited by 110
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia
Lorenzl, S., Büerger, K., Hampel, H. J., & Beal, M. F. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207005790 · Cited by 105
Gonçalves, F. M., Jacob‐Ferreira, A. L., Gomes, V. A., Casella–Filho, A., Chagas, A. C. P., Marcaccini, A. M., Gerlach, R. F., & Tanus-Santos, J. E. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.02.013 · Cited by 104
Increased soluble tumor necrosis factor‐α receptors in patients with major depressive disorder
Grassi‐Oliveira, R., Brietzke, E., Pezzi, J. C., Lopes, R. P., Teixeira, A. L., & Bauer, M. E. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01918.x · Cited by 92 · cited 1×
“RII, consistent with recent findings [43–45], we did not observe”
ResultMaes, M. H. J., Wauters, A., Neels, H. M., Scharpé, S., Gastel, A. V., D'Hondt, P., Peeters, D., Cosyns, P. R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)00106-j · Cited by 89
TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population.
Himmerich, H., Fulda, S., Linseisen, J., Seiler, H., Wolfram, G., Himmerich, S., Gedrich, K., & Pollmächer, T. (2006) · PubMed · Cited by 87
Narita, K., Murata, T., Takahashi, T., Kosaka, H., Omata, N., & Wada, Y. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.030 · Cited by 84
Increased serum levels of CCL11/eotaxin in schizophrenia
Teixeira, A. L., Reis, H. J., Nicolato, R., Brito-Melo, G., Corrêa, H., Teixeira, M. M., & Romano‐Silva, M. A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.11.019 · Cited by 84
Lee, B.-H., & Kim, Y. (2009) · Neuropsychobiology · doi:10.1159/000205518 · Cited by 74
Hunsel, F. V., Wauters, A., Vandoolaeghe, E., Neels, H. M., Demedts, P., & Maes, M. H. J. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)03010-7 · Cited by 67
Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice
Chaillan, F. A., Rivera, S., Marchetti, E., Jourquin, J., Werb, Z., Soloway, P. D., Khrestchatisky, M., & Roman, F. S. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.06.020 · Cited by 53
No changes in serum epidermal growth factor levels in patients with schizophrenia
Hashimoto, K., Shimizu, E., Komatsu, N., Watanabe, H., 篠田, 直., Nakazato, M., Kumakiri, C., Okada, S., Takei, N., & Iyo, M. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2003.11.006 · Cited by 17
Tashiro, A., Hongo, M., Ota, R., Utsumi, A., & Imai, T. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1924 · Cited by 16
Biological Markers of Depression
Connor, T., & Leonard, B. E. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18500-7_4 · Cited by 14
Cited by
Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer
Chen, W., Liu, F., Ling, Z., Tong, X., & Xiang, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039743 · Cited by 1,034
A review of depression and suicide risk assessment using speech analysis
Cummins, N., Scherer, S., Krajewski, J., Schnieder, S., Epps, J., & Quatieri, T. F. (2015) · Speech Communication · doi:10.1016/j.specom.2015.03.004 · Cited by 1,003
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
Metadata
- Authors
- Domenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., Holsboer, F., Bullmore, E. T., Middleton, L., Merlo-Pich, E., Alexander, R. C., & Muglia, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-11
- Volume
- 5
- Issue
- 2
- Pages
- e9166
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2007353040
- Cited by
- 347
- References
- 54
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.